Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04771936
Other study ID # 2395
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 28, 2021
Est. completion date June 30, 2022

Study information

Verified date November 2022
Source University of Malta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Osteoarthritis (OA) is a common disease that occurs more commonly amongst the elderly and is caused by the destruction of the joint cartilage. It is considered to be one of the most common joint disorders worldwide and a main cause of disability amongst older adults. After the knee, the hip is considered to be the second most commonly affected joint by OA. One of the functional capacities affected by OA is muscle strength with studies looking into knee OA documenting a decrement of this measure. It is reported that the muscle strength of the quadriceps, hamstrings and other musculature around the hip is significantly impaired in patients with knee OA compared to age-matched controls. Evidence for quadriceps muscle weakness in knee OA is consistent and programs based on quadriceps strengthening exercises as a core component in the management of knee OA are now evidence-based. Lower extremity muscle weakness is also apparent in hip OA. However, compared to the knee, there is less literature on muscle strength in hip OA with guidelines for therapeutic exercise prescription being more expert rather than evidence-based. Therefore, one of the major questions that arises here is whether muscle weakness as observed in knee OA is evident in hip OA, and if so, which muscles are most affected. A concept which has been found to help diminish the effect of decreased muscle strength in the above mentioned muscle groups is optimal core stability. Core stability contributes to strength, endurance, flexibility and motor control all of which optimise the stability of the spine during both dynamic and static tasks in daily normal biomechanical function in patients with a diagnosis of OA knees. Despite such evidence, no studies to the knowledge of the researcher have looked into the effects of core stability on pain and functional levels in patients with a diagnosis of OA hip. A lack of literature in relation to this aspect is due to the unavailability of a gold standard for measuring core stability. Therefore, the objective of this study will be multifold with an investigation into which muscles in the lower limb are predominantly weaker, whether there is core muscle weakness in patients with hip OA, looking for any correlation between both these factors and whether an exercise programme leads to changes on functional activity and pain levels.


Description:

Osteoarthritis (OA) is a common disease that occurs more commonly amongst the elderly and is caused by the destruction of the joint cartilage. It is considered to be one of the most common joint disorders worldwide and a main cause of disability amongst older adults. After the knee, the hip is considered to be the second most commonly affected joint by OA. One of the functional capacities affected by OA is muscle strength with studies looking into knee OA documenting a decrement of this measure. The muscle strength of the quadriceps, hamstrings and other musculature around the hip is significantly impaired in patients with knee OA compared to age-matched controls. Evidence for quadriceps muscle weakness in knee OA is consistent and programs based on quadriceps strengthening exercises as a core component in the management of knee OA are now evidence-based. Lower extremity muscle weakness is also apparent in hip OA. However, compared to the knee, there is less literature on muscle strength in hip OA with guidelines for therapeutic exercise prescription being more expert rather than evidence-based. Therefore, one of the major questions that arises here is whether muscle weakness as observed in knee OA is evident in hip OA, and if so, which muscles are most affected. A concept which has been found to help diminish the effect of decreased muscle strength in the above mentioned muscle groups is optimal core stability. Core stability contributes to strength, endurance, flexibility and motor control all of which optimise the stability of the spine during both dynamic and static tasks in daily normal biomechanical function in patients with a diagnosis of OA knees. Despite such evidence, no studies to the knowledge of the researcher have looked into the effects of core stability on pain and functional levels in patients with a diagnosis of OA hip. Lack of literature in relation to this aspect is due to the unavailability of a gold standard for measuring core stability. Therefore, the objective of this study will be multifold with an investigation into which muscles in the lower limb are predominantly weaker, whether there is core muscle weakness in patients with hip OA, looking for any correlation between both these factors and whether an exercise programme leads to changes on functional activity and pain levels. All the patients who give consent to participate shall be randomly assigned to three groups being the control group who shall be awaiting surgery and not receiving a regular physiotherapy exercise intervention, the exercise group who shall be subject to a set of conventional exercises based and a core exercise group who shall be performing the conventional exercises plus exercises aimed at the activation of the core muscles. These exercises shall be carried out three times weekly for a period of three months. During the first four weeks, all sessions shall be supervised by a physiotherapist who shall monitor and increase the duration or difficulty of exercises according to patients' progression. From the 5th to the 8th week, patients shall attend two supervised sessions and complete the third one at home. Between the 9th and the 12th week, patients shall then attend one supervised intervention and complete two exercise sessions at home. All patients shall be given a copy of the exercise sheet with instructions for use at home. Anonymisation shall be ensured with every patient through assignment of a random code for every individual. Patients assigned to the control group shall be given a chance to enrol into the program upon completion of the study if they wish to do so.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date June 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: - Patients awaiting a total hip replacement - Anyone above the age of 40 years Exclusion Criteria: - Patients with neurologic conditions affecting mobility - Patients with cognitive impairments - Patients not willing to comply

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physiotherapy Exercises
All patients shall be randomly assigned to 3 groups: the control group who shall be awaiting surgery and not receiving a regular physiotherapy, the exercise group who shall be subject to a set of conventional exercises and a core exercise group who shall be performing the conventional exercises plus exercises aimed at the activation of core muscles. These exercises shall be carried out 3 times weekly for a period of 3 months. During the first 4 weeks, all sessions shall be supervised by a physiotherapist. From the 5th to the 8th week, patients shall attend 2 supervised sessions and complete the 3rd one at home. Between the 9th and the 12th week, patients shall then attend 1 supervised intervention and complete 2 sessions at home.Patients assigned to the control group shall be given a chance to enrol into the program upon completion of the study if they wish to do so.

Locations

Country Name City State
Malta Faculty of Health Sciences Imsida

Sponsors (1)

Lead Sponsor Collaborator
University of Malta

Country where clinical trial is conducted

Malta, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in pain levels assessed using the Numerical Pain Rating Scale (NPRS) The NPRS is a type of pain scale widely used in the clinical setting aswell as in research. The research found that the NPRS is a simple and valid tool to use with Cleland et al (2008) reporting acceptable construct validity for this tool (p < 0.001). It is usually presented on a horizontal line on which the patient's pain intensity is represented by a point between the marks of 0 (no pain) to 10 (extreme pain). The NPRS is a segmented, numerical version of the Visual Analogue Scale (VAS), as shown in the image below. Its simplicity, reliability, and validity make the NPRS the optimal tool for describing pain severity or intensity (The British Pain Society, 2019). Week 0 and week 12
Primary Change in functional Levels assessed using the WOMAC Scale The Western Ontario and McMaster Universities (WOMAC) is a widely used instrument which is specific to assessing patients with hip and knee OA. This assessment tool is self- administered and is multidimensional (Bellamy, 2008). It consists of 33 items which evaluate the health and function of the patient from various aspects including clinical symptoms (5 questions), severity of joint stiffness (2 questions), degree of pain (9 questions), and activity of daily living (17 questions). Each question has five subscales were the subject score between situations of never or none to situations of extreme or always. A higher score is a representation of a better situation and less pain. Different validation studies of WOMAC make this clinical instrument usable for knee and hip OA and enable clinical investigators to assess those clinical outcome reports using this index from different parts of the world collectively (Ebrahimzadeh et al, 2014). Week 0 and week 12
Primary Change in functional Levels assessed using the 6 MWT The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway. Such a test has been reported to be a valid and reliable indicator of aerobic fitness (ATS guidelines, 2002). It is considered to be a useful objective baseline measure and has normative results and minimal clinically important differences established for a range of older individuals. The subjects will be instructed that they may stop and rest during the test, but the time will keep running. At the end of the six minutes, the time walked and distance will be noted and recorded. Standardised encouragement is provided at 1-minute intervals, and the person should not be paced. Individuals may use assistive devices during the test (ATS guidelines, 2002). Week 0 and week 12
Primary Change in lower limb muscle strength All subjects will undergo peak isometric lower limb muscle torque testing for the following muscle groups: Quadriceps, Hamstrings, Adductors and Abductors using a dynamometer. A demonstration on how to carry out the test correctly will be done together with a single trial to familiarise with the participants with the technique and procedure. A maximum of three attempts will be performed with the average result taken. Participants will be instructed to exert maximal effort and will be verbally coached to push as hard as they can for each recorded trial. Week 0 and week 12
Primary Change in core Muscle Strength using a pressure biofeedback unit (PBU) Participants will be placed in a supine position with the pelvis over the pressure biofeedback unit (PBU) and their hands resting over their chest. The PBU will be placed under the lumbar spine at the level of L3, with a pressure of 40 mm Hg. The participants will be asked to place their hip in flexion or their knee in flexion/extension while in the supine position. They will be asked to 'Take a deep breath in and draw their navel in toward their spine as they exhale'. Each participant will be asked to hold the contraction for as long as they can while maintaining the contraction at 40mmHg on the PBU gauge. Those able to maintain the abdominal contraction for at least 10 seconds at 40 mmHg will be considered as having good core strength. Those unable to hold the contraction for 10 seconds at the mentioned pressure will be considered as having a weak core (Rajan Bhore et al, 2019). Week 0 and week 12
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05773261 - Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups N/A
Recruiting NCT05223777 - KINCISEā„¢ Surgical Automated System in Total Hip Arthroplasty (THA) N/A
Recruiting NCT04731077 - Avenir Complete Post-Market Clinical Follow-Up Study N/A
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT06162195 - The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement N/A
Withdrawn NCT02743208 - Evaluation of a Short Femoral Stem in Total Hip Arthroplasty N/A
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Active, not recruiting NCT02229279 - Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures N/A
Active, not recruiting NCT02851992 - A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem N/A
Completed NCT01700933 - Dose-response: Exercise Therapy on Hip Osteoarthritis N/A
Completed NCT01618708 - A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip N/A
Completed NCT01214954 - Early Rehabilitation After Total Hip Replacement N/A
Active, not recruiting NCT00294424 - Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements N/A
Terminated NCT00588861 - Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement N/A
Withdrawn NCT05054595 - Audio-Recorded vs. Nurse-Led Brief Mindfulness-Based Intervention N/A
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Recruiting NCT05014113 - H-28 DELTA ST-C and Minima Retrospective Study.
Completed NCT01066936 - Mini Stem DEXA (Dual Energy X-ray Absorptiometry)
Recruiting NCT05530551 - Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA N/A